Abanoquil

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C22H25N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F738MWY53L, chemically known as 4-quinolinamine, 2-(3,4-dihydro-6,7-dimethoxy-2(1h)-isoquinolinyl)-6,7-dimethoxy-, monomethanesulfonate but generally known as abanoquil, which bears US NIH Compound Identifier 164088. Abanoquil also appears in mesilate or mesylate form. European Medicines Agency schedules Abanoquil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07358MIG. The term ABANOQUIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). ABANOQUIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule abanoquil under HS 29334990 and SITC 51575. As of Q4 2014, ABANOQUIL remains the US FDA Preferred Term for this commodity. Abanoquil bears US NLM identifiers UMLS ID C0165215 and NCI Concept Code C72566. SMILES: S(=O)(=O)(O)C.O(C1CC2CCN(CC2CC1OC)C1NC2C(C(N)C1)CC(OC)C(OC)C2)C.